Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs allopurinol in gout hyperuricemia (China phase 3)
CTR20150590Phase 3Completed
- Sponsor
- Beijing Wanquan Sunshine Pharmaceutical Technology
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of febuxostat in hyperuricemia, gout, sponsored by Beijing Wanquan Sunshine Pharmaceutical Technology. Started Dec 2015; status: completed.
02
Drugs
febuxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20150590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150590.